Mark Wakefield
Overview
Explore the profile of Mark Wakefield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Whittington M, Goggin K, Noel-MacDonnell J, Hathaway D, Remy L, Aholt D, et al.
J Healthc Qual
. 2022 Jun;
44(4):240-252.
PMID: 35759613
Interventions to improve medication nonadherence in transplantation have recently moved from a focus on motivation and intention, to a focus on person-level quality improvement strategies. These strategies link adherence to...
2.
Kou L, Zhu Z, Redington C, Bai Q, Wakefield M, Lequio M, et al.
Med Oncol
. 2021 Feb;
38(3):25.
PMID: 33586074
Skin cancers are the most common cancers in the world and among the different types of skin cancers, melanoma is the deadliest and incidence is rising. Previous studies have shown...
3.
Hockman L, Bailey J, Sanders J, Muzzey C, Wakefield M, Christensen A, et al.
Res Rep Urol
. 2020 Oct;
12:447-453.
PMID: 33117744
Purpose: To evaluate patient satisfaction (with emphasis on preoperative education) with radical cystectomy for bladder cancer at our institution, the University of Missouri Hospital, qualitatively in order to identify specific...
4.
Anwar T, Wakefield M, Murray K
J Urol
. 2020 Mar;
203(6):1070-1071.
PMID: 32202460
No abstract available.
5.
Russell C, Hathaway D, Remy L, Aholt D, Clark D, Miller C, et al.
Am J Transplant
. 2019 Jul;
20(1):125-136.
PMID: 31291507
This study determined if a SystemCHANGE™ intervention was more efficacious than attention control in increasing immunosuppressive medication adherence and improving outcomes in adult kidney transplant recipients during a 6-month intervention...
6.
Murray K, Prunty M, Henderson A, Haden T, Pokala N, Ge B, et al.
Urology
. 2018 Aug;
121:39-43.
PMID: 30076943
Objective: To evaluate the ability to perform activities of daily living (ADLs) in patients who required nursing home (NH) care after radical cystectomy (RC), as this surgery can impair patients'...
7.
Waung M, Akerman S, Wakefield M, Keywood C, Goadsby P
Ann Clin Transl Neurol
. 2016 Sep;
3(8):560-71.
PMID: 27606340
Introduction: Many patients suffering from migraine gain little relief from existing treatments partly because many existing acute and preventive therapies used in migraine have been adopted from other neurologic conditions...
8.
Tison F, Keywood C, Wakefield M, Durif F, Corvol J, Eggert K, et al.
Mov Disord
. 2016 May;
31(9):1373-80.
PMID: 27214664
Background: The metabotropic glutamate receptor 5-negative allosteric modulator dipraglurant reduces levodopa-induced dyskinesia in the MPTP-macaque model. The objective of this study was to assess the safety, tolerability (primary objective), and...
9.
Yeast C, Riley J, Holyoak J, Ross Jr G, Weinstein S, Wakefield M
Int Braz J Urol
. 2016 May;
42(1):107-12.
PMID: 27136475
Introduction: After a failed transplant, management of a non-functional graft with pain or recurrent infections can be challenging. Transplant nephrectomy (TN) can be a morbid procedure with the potential for...
10.
Russell C, Conn V, Ashbaugh C, Madsen R, Wakefield M, Webb A, et al.
Clin Transplant
. 2010 Nov;
25(6):864-70.
PMID: 21077956
Background: Immunosuppressive medication non-adherence is one of the most prevalent but preventable causes of poor outcomes in adult renal transplant recipients, yet there is a paucity of studies testing interventions...